Insulin receptors in vascular smooth muscle cells regulate plaque stability of atherosclerosis.

Aims

Increased prevalence of acute myocardial infarction related to diabetes and insulin resistance is associated with an elevated risk of unstable atherosclerotic plaques, which are characterized by reduced vascular smooth muscle cells (VSMCs) and extracellular matrix (ECM) and increased inflammation. Thus, insulin resistance may reduce plaque stability, as deleting insulin receptors (IRs) in VSMCs decreases their proliferation and enhances apoptosis.

Methods and results

Direct effects of insulin on VSMCs to alter plaque composition were studied using mice with double knockout of ApoE and IR genes in VSMCs with SMIRKO/ApoE-/-, Myh11-CreERT2EYFP+/ApoE-/-, and Myh11-CreERT2EYFP+IRKO/ApoE-/- mice, which were also used for lineage tracing studies. Compared with ApoE-/- mice, SMIRKO/ApoE-/- mice exhibited more atherosclerotic plaques, which contained less VSMCs and collagen but increased levels of VSMC apoptosis and necrotic areas. Lineage tracing studies showed that Icam1+ Vcam1+ VSMC was inflammatory, which increased in the aortas of Myh11-CreERT2EYFP+IRKO/ApoE-/- mice compared with control mice. Isolated VSMCs lacking IRs expressed higher inflammatory cytokines than cells with IRs. Cell-based studies indicated that insulin's anti-apoptotic and pro-proliferative effects in VSMCs were mediated via activation of the IR/Akt pathway, which were decreased in VSMCs from SMIRKO or high-fat diet mice. An analysis of the IR targets that regulated inflammatory cytokines in VSMCs showed that thrombospondin 1 (Thbs1) and Mmp2 were consistently increased with a loss of IRs. Insulin inhibited Thbs1 expression, but not Mmp2 expression, through p-Akt/p-FoxO1 pathways in VSMCs from ApoE-/- mice, and was impaired in cells from SMIRKO/ApoE-/- mice. Thbs1 further induced Icam1 and Mmp2 expressions in VSMCs.

Conclusion

Insulin via IRs has significant actions in VSMCs to decrease inflammation, apoptosis, and ECM turnover via the activation of Akt and FoxO1 pathways. The inhibition of insulin actions and related pathways related to insulin resistance and diabetes may contribute to the formation of unstable atherosclerotic plaques.

COI Statement

Conflict of interest: none declared.

References:

• Rawshani  A, Rawshani  A, Franzen  S, Eliasson  B, Svensson  AM, Miftaraj  M, McGuire  DK, Sattar  N, Rosengren  A, Gudbjornsdottir  S. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med  2017;376:1407–1418.
• Burke  AP, Kolodgie  FD, Zieske  A, Fowler  DR, Weber  DK, Varghese  PJ, Farb  A, Virmani  R. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol  2004;24:1266–1271.
• Virmani  R, Burke  AP, Kolodgie  FD, Farb  A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol  2002;15:439–446.
• Howard  G, O'Leary  DH, Zaccaro  D, Haffner  S, Rewers  M, Hamman  R, Selby  JV, Saad  MF, Savage  P, Bergman  R. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation  1996;93:1809–1817.
• Bonora  E, Kiechl  S, Willeit  J, Oberhollenzer  F, Egger  G, Meigs  JB, Bonadonna  RC, Muggeo  M. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care  2007;30:318–324.